Back to Search
Start Over
SLAMF7 (CD319/CS1) is expressed in plasmablastic lymphoma and is a potential diagnostic marker and therapeutic target
- Source :
- British journal of haematology. 185(1)
- Publication Year :
- 2018
- Subjects :
- Pathology
medicine.medical_specialty
Immunophenotyping
03 medical and health sciences
0302 clinical medicine
Text mining
Signaling Lymphocytic Activation Molecule Family
medicine
Biomarkers, Tumor
Humans
Molecular Targeted Therapy
business.industry
SLAMF7
Diagnostic marker
Hematology
medicine.disease
Prognosis
Phenotype
Immunohistochemistry
030220 oncology & carcinogenesis
Plasmablastic Lymphoma
Antibody therapy
business
Plasmablastic lymphoma
Biomarkers
030215 immunology
Subjects
Details
- ISSN :
- 13652141
- Volume :
- 185
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- British journal of haematology
- Accession number :
- edsair.doi.dedup.....f24d80f659cd142ecdb1f65d4314d2fe